⌘K

Login Start Free

Home/Filings/4/0001697422-25-000004

4//SEC Filing

Fenimore Christopher R. 4

Accession 0001697422-25-000004

CIK 0000872589other

View on SEC.gov Company Profile

Filed

Dec 8, 7:00 PM ET

Accepted

Dec 9, 4:08 PM ET

Size

11.4 KB

Accession

0001697422-25-000004

Insider Transaction Report

Form 4

Period: 2025-12-05

REGENERON PHARMACEUTICALS, INC.REGN

Fenimore Christopher R.

VP, Controller

Transactions

Award
Common Stock
2025-12-05+3,027→ 19,292 total
Tax Payment
Common Stock
2025-12-08$712.94/sh−992$707,236→ 18,300 total
Award
Non-Qualified Stock Option (right to buy)
2025-12-05+14,924→ 14,924 total
Exercise: $726.71Exp: 2035-12-05→ Common Stock (14,924 underlying)

Holdings

Common Stock
(indirect: By 401(k))
1,548
Common Stock
(indirect: By Trust)
1,897
Common Stock
(indirect: By Trust)
25

Footnotes (3)

[F1]Award of Restricted Stock under the Second Amended and Restated 2014 Long-Term Incentive Plan that vests 50% on December 5, 2027 and 50% on December 5, 2029.
[F2]These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust.
[F3]The stock option award vests in four equal annual installments, commencing one year after the date of grant.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

REGENERON PHARMACEUTICALS, INC.

CIK 0000872589

Entity typeother

Related Parties

1

filerCIK 0001697422

Filing Metadata

Form type: 4
Filed: Dec 8, 7:00 PM ET
Accepted: Dec 9, 4:08 PM ET
Size: 11.4 KB

View on SEC.gov